U.S. Options Are Limited in the Ongoing Trade War with China

President Donald Trump said in early July that the COVID-19 pandemic has “severely damaged” the U.S.’s relationship with China. He added that he isn’t thinking about the next stage of the trade deal with the Asian superpower. To get more context on how these tensions have affected trade between the countries, GLG spoke with David […]

GLG Signature Series: David Plouffe, Campaign Manager for Barack Obama

Recently, David Plouffe, the former campaign manager for Barack Obama and current board member of the liberal nonprofit ACRONYM, sat down for a 60-minute virtual session with select GLG clients. As Obama assumed office, Plouffe was initially an outside senior advisor to the President. After David Axelrod’s resignation, he was appointed as a Senior Advisor […]

Slouching Toward November: Presidential Election Forecast

The 2020 presidential election promises to be both a contentious and a consequential one. With the specter of COVID-19 hovering over the proceedings and the hazard of voter disenfranchisement, the threat to a free and fair election is very real. GLG sat down with Robby Mook, the former Presidential Campaign Manager for Hillary Clinton, to […]

Understanding the Executive Order on Online Censorship

On May 28, 2020, President Donald J. Trump signed an executive order banning censorship by online platforms. To discuss the order and its possible impact, GLG talked to Tom Wheeler, former Chairman of the Federal Communications Commission and former Chairman of the Cellular Telecommunications and Internet Association. Edited excerpts of the discussion follow. A key […]

COVID-19: Federal, State, and City Response

What role should federal agencies play during the COVID-19 pandemic? Should the government provide supplies to health providers across the country? To learn more about federal responses to emergencies, Michael Weissman of GLG’s healthcare team spoke with Greg Burel, former Director of the Division of Strategic National Stockpile (DSNS) at the Centers for Disease Control […]

How Speaker Pelosi’s Drug Bill May Impact the Price of Drugs

A bill crafted by House Speaker Nancy Pelosi intended to reduce drug prices will make its way to the House floor after the House Ways and Means Committee approved it on Sept. 22. H.R.3 – Lower Drug Costs Now Act of 2019 would permit The Centers for Medicare and Medicaid Services (CMS), an agency within the U.S. Department […]

U.S. – China Relations

The landmark Paris Climate Agreement marked a breakthrough in U.S.-China relations. New York University Professor of Finance and Economics Ann Lee discusses the potential fallout of an American reversal on the agreement, as President-elect Donald Trump suggested on the campaign trail. Lee also outlines how an infusion of Chinese capital could help build new infrastructure […]

Decisions in the West Wing

Jake Sullivan, a former advisor to President Barack Obama, discusses the delicacy of the policy-making process. Sullivan explains his involvement in the Iran nuclear deal and the often hard-to-discern, real-world consequences of implementing new policies across the globe. Interviewed by Eric Jaffe, GLG’s Head of Research for NAFS   “Somebody can always come along and […]

The Affordable Care Act

Elizabeth Canis discusses the questions and implications around the potential repeal of the Affordable Care Act. For Canis, sustainable change means understanding the complexity of the legislation and finding bipartisan support for alternatives. Whatever result the administration’s policies have on healthcare in America, reducing the cost trajectory and addressing cost transparency will be critical to […]

Renewable Energy and Clean Tech

The energy revolution is well underway. As traditional oil and gas companies transition into new energy businesses, the legacy of President Obama’s energy policies will largely carry over into the next administration, according to energy expert Peter Fusaro. He predicts that over the next few years, the start of the hydrogen economy will take effect—regardless […]

Decisions on the Campaign Trail

Former Hillary Clinton campaign manager Robby Mook gives us his take on Russian interference in the 2016 presidential election, why organizations should prepare themselves for major disruptions, and what mistakes were made during the campaign. Interviewed by Richard Socarides, GLG’s Head of Public Affairs   “A lot of the data was wrong in this campaign…But […]

Speaker Biographies

Hilary Malone PhD, has over 25 years of experience in global drug development, regulatory &government affairs, manufacturing and commercialization within the biopharma industry. Hilary hassignificant board level and executive committee experience including large scale organizationalrestructuring/transformation/integration, major M&A, biotech start-up, capital raising, investorrelations and pre-IPO.​

Hilary is currently CEO of Stylus Medicine, a private genetic medicine biotech company. Previously sheserved as CEO of a Series-A neuroscience company. Prior to these roles, Hilary served as COO & EVP atValo Health Inc., Chief Regulatory Officer & SVP at Sanofi Inc., and Chief Regulatory Officer & SVP atPfizer and Wyeth. Previous experience also includes senior regulatory and drug development roles atReata Pharmaceuticals Inc., AstraZeneca plc and GlaxoSmithKline plc.​

Hilary also serves on the Board of Directors of Hansa Biopharma and Adthera Bio. Hilary holds a PhD inMolecular Neuropharmacology and a BSc in Physiology.

Dr. Thomas Lönngren is Director at his own company PharmaExec Consulting AB. He is the Chairman of the Board of directors at Egetis Therapeutics AB, Sweden. Dr Lönngren also serves as board member at Compass Pathways PLC, London UK and NDA Group, Sweden. He acts as advisor to the following companies and organizations: NDA group, Sweden, Sweden, Artis Venture, San Francisco, US, Fujimoto Japan, Skin2Neuron Pty Ltd, Sydney, Australia, US, Special advisor to the Centre for Innovation in Regulatory Science (CIRS), London UK. From 2001 until2011, Mr.Lönngren served as the Executive Director of the European Medical Agency. He was previously Deputy General Director of the Swedish Medical Product Agency until 2000. He has a degree in pharmacy and MSc in Social and Regulatory Pharmacy from Uppsala University. He is also an Honorary Member of the Royal Pharmaceutical Society of Great Britain, Honorary Fellow of the Royal College of Physicians in Great Britain, Honorary Doctorate from the University of Uppsala, Honorary Doctorate from University of Bath, UK.

Speaker Biographies

Marie-Anne Aymerich

Marie-Anne has built a portfolio of senior advisory and non-executive roles, following a successful international career in the FMCG and Luxury sectors. She is a non-executive director of Haleon, a FTSE100 company listed in 2022 after the demerger from GSK. She is also chairwoman of Haleon Environment and Societal Sustainability committee. She is the executive director of the Pierre Fabre Group where she also sits on the Strategic Committee, and she is a Board Member of The Academy of St. Martin-in-the-Fields, one of the world’s most prestigious chamber orchestras. She is also an angel investor and focuses her time and investments on start-ups with the strongest purpose and impact.

Marie-Anne is also a regular lecturer at HEC Paris on purposeful leadership, and she has created a serious game called “Planet Purpose” to upskill people on sustainability and purpose. Throughout her 35year executive career she delivered a strong track-record of business performance and growth in brands and portfolio in both developed and emerging economies.

As a senior leader with Unilever, she led a number of different personal care categories across France, Spain and the USA – including managing the Dove brand worldwide and culminating in leading Unilever’s global Oral Care division. She also worked for LVMH as Brand General Manager of Dior Perfumes and Cosmetics worldwide. Marie-Anne was also Vice-President of Imagine for Margo – Children with Cancer for ten years, a charity she helped found in 2011 with the goal of eradicating children’s cancer. The charity is the #1 charity focused on child cancer in France and has fundraised more than €14m since its creation. Marie-Anne is a graduate from HEC Paris. She is married and has two children aged 29 and 26.

Patrick Jephson

Patrick Jephson is a consultant, journalist, broadcaster and New York Times bestselling author, based in Washington D.C. He is a published authority on corporate and personal branding and crisis communications, addressing conferences worldwide as well as events at the U.S. State Department, the American University and the Annenberg School for Communication and Journalism.

With more than twenty-five years’ experience in the government, luxury and family office sectors, Patrick’s portfolio has included globally admired brands as well as national agencies and NGOs. He has also worked on reputation and legacy briefs with European, Middle Eastern and Asian families, including royalty. He now writes, presents, and advises on factual and drama TV programs, appearing on every major American and many international networks. He was recently an expert consultant to the award-winning Netflix series The Crown and provided live commentary on the Coronation of King Charles.

Patrick owes much of his practical communications and protocol experience to Princess Diana, who chose him to be her equerry and only private secretary/chief of staff. He served the Princess for eight years, responsible for all aspects of her public life, global humanitarian initiatives, and private organization. Having worked for an internationally high-profile woman (and as the father of two professionally successful daughters) he feels a special affinity for cross-cultural, gender and perception issues.

Patrick was born and raised in Ireland and holds a master’s degree in political science from Cambridge University. As an officer in the British Royal Navy, he served all over the world before being selected for royal duty. He is a citizen of the U.K., U.S.A., Ireland, and Canada.